Charles & Colvard, a company specializing in moissanite and lab-grown diamonds, is once again at risk of being delisted from Nasdaq. The latest notice, received on October 18, was issued due to the company’s failure to submit its annual 10-K form for the fiscal year ending June 30, which was due by September 30. Although Charles & Colvard filed for a late submission on October 1, Nasdaq has given the company until December 17 to comply or present a plan for regaining compliance. If accepted, the company would have until April 14, 2025, to file the necessary documentation.
This warning has no immediate impact on its stock, and Charles & Colvard has indicated it is working diligently to submit the report. Earlier in the year, the company initiated a reverse stock split to meet Nasdaq’s $1 minimum share price requirement. As of the latest report, shares were trading at $1.25.